Jeffrey S Murley Selected Research

fulvene-5

1/2018

ROS modifiers and NOX4 affect the expression of the survivin-associated radio-adaptive response.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeffrey S Murley Research Topics

Disease

13	Neoplasms (Cancer) 01/2017 - 01/2002
7	Sarcoma (Soft Tissue Sarcoma) 04/2015 - 01/2002
4	Carcinoma (Carcinomatosis) 01/2018 - 01/2011
2	Genomic Instability 02/2010 - 12/2008
2	Neoplasm Metastasis (Metastasis) 12/2002 - 01/2002
2	Glioma (Gliomas) 05/2002 - 01/2002
1	Inflammation (Inflammations) 12/2011
1	Critical Illness (Critically Ill) 12/2011
1	Lung Injury 12/2011
1	Ventilator-Induced Lung Injury 12/2011
1	Colorectal Neoplasms (Colorectal Cancer) 04/2007
1	Hypoxia (Hypoxemia) 10/2004
1	Head and Neck Neoplasms (Head and Neck Cancer) 05/2002
1	Xerostomia 05/2002
1	Anemia 01/2002

Drug/Important Bio-Agent (IBA)

14	Amifostine (Ethyol)FDA LinkGeneric 02/2013 - 01/2002
11	N-(2-mercaptoethyl)-1,3-diaminopropaneIBA 02/2013 - 01/2002
6	Sulfhydryl Compounds (Thiols)IBA 02/2013 - 01/2002
4	Superoxide DismutaseIBA 02/2013 - 01/2002
3	SurvivinIBA 01/2018 - 04/2015
3	Emodin (Archin)IBA 01/2018 - 10/2016
3	Pharmaceutical PreparationsIBA 01/2017 - 02/2002
3	Transcription Factors (Transcription Factor)IBA 04/2015 - 01/2002
3	AntioxidantsIBA 12/2011 - 05/2002
2	Metformin (Glucophage)FDA LinkGeneric 01/2018 - 01/2017
2	Acetylcysteine (Siran)FDA LinkGeneric 01/2018 - 01/2017
2	RotenoneIBA 01/2018 - 01/2017
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017 - 12/2011
2	Proteins (Proteins, Gene)FDA Link 10/2016 - 01/2002
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 07/2013 - 02/2013
2	superoxide dismutase 2IBA 12/2011 - 11/2004
2	CatalaseIBA 12/2011 - 03/2009
2	AngiostatinsIBA 12/2002 - 01/2002
1	fulvene-5IBA 01/2018
1	honokiolIBA 01/2018
1	Radiation-Sensitizing AgentsIBA 01/2017
1	BiguanidesIBA 01/2017
1	NitrogenIBA 12/2011
1	EnzymesIBA 12/2011
1	LipopolysaccharidesIBA 12/2011
1	Oxygen (Dioxygen)IBA 12/2011
1	Thrombin FDA Link 12/2011
1	Glutathione PeroxidaseIBA 03/2009
1	Protective AgentsIBA 12/2008
1	3- (4- methylphenylsulfonyl)- 2- propenenitrileIBA 11/2004
1	Mesna (Coenzyme M)FDA LinkGeneric 11/2004
1	Captopril (Capoten)FDA LinkGeneric 11/2004
1	NF-KappaB Inhibitor alphaIBA 11/2004
1	Free RadicalsIBA 10/2004
1	HydrogenIBA 10/2004
1	Matrix Metalloproteinases (MMPs)IBA 01/2002
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2002
1	P-SelectinIBA 01/2002
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2002
1	E-SelectinIBA 01/2002
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2002
1	InterleukinsIBA 01/2002
1	Epoetin Alfa (Epogen)FDA Link 01/2002
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2002
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2002
1	Interleukin-8 (Interleukin 8)IBA 01/2002
1	Interleukin-6 (Interleukin 6)IBA 01/2002

Therapy/Procedure

4	Therapeutics 11/2004 - 02/2002
3	Radiotherapy 03/2009 - 01/2002
2	Image-Guided Radiotherapy 10/2016 - 07/2013
2	Surgical Amputation (Amputations) 12/2002 - 01/2002
1	Intraperitoneal Injections 12/2011
1	Artificial Respiration (Mechanical Ventilation) 12/2011
1	Drug Therapy (Chemotherapy) 10/2004
1	Aftercare (After-Treatment) 01/2002